Appointments
Request Appointment/Request Exam - After completing the respective forms, these requests will be processed by our services, and you will receive confirmation by email. The indications about the Agreements (Insurance/Subsystem) are merely informative, please request confirmation in the "Observations" field.
Schedule Appointment/Exam myHPA - By accessing myHPA Saúde you can make the appointment in real time, directly on the Doctor's schedule according to his availability.
You can also contact us at +351 282 420 400 Algarve | +351 269 630 370 Alentejo | +351 291 003 300 Madeira
Phone booking/service hours:
Monday to Friday: 8:00 AM to 7:00 PM, Saturday: 8:00 AM to 5:00 PM Sunday and Holidays: Closed
(National landline)
Your request has been successfully received. We will confirm your appointment shortly.
Download myHPA Saúde:
HPA Health Group Newsletter:
Subscribe and stay up to date with all the news!
Weight Loss Consultation GLP-1
Treatment for excess weight based on an innovative pharmacological therapy with GLP-1 agonists.
The Weight Loss Consultation with personalised medical support is aimed at patients with excess weight or obesity. This new approach combines a specialised clinical assessment with an innovative treatment based on GLP-1 agonists, promoting safe, effective, and sustainable weight loss.
The Weight Loss Consultation is particularly beneficial for patients with prior knowledge of healthy eating and who are willing to engage in a suitable level of physical exercise tailored to their individual characteristics.
- Dr. Ricardo Gabriel
Instituto HPA - Montenegro – Faro
What are GLP-1 agonists?
GLP-1 receptor agonists are medications that mimic the action of the hormone GLP-1 (glucagon-like peptide-1), naturally produced by the intestine after meals.
These drugs act on several metabolic mechanisms, contributing to:
- Reducing appetite;
- Increasing satiety;
- Sustained reduction of body weight;
- Improving blood sugar control.
Who can benefit from the Weight Loss Consultation?
Inclusion Criteria:
- People with a Body Mass Index (BMI) ≥ 30 kg/m² (obesity);
- Or BMI ≥ 27 kg/m² with associated conditions such as hypertension, prediabetes, and elevated cholesterol, among others;
- Aged 18 years or older;
- Motivated to lose weight under clinical supervision.
Exclusion Criteria:
- Pregnancy or breastfeeding;
- Family history of medullary thyroid cancer or MEN2 syndrome (Multiple Endocrine Neoplasia type 2);
- History of pancreatitis or severe pancreatic disease;
- Advanced renal or liver disease.
How is the treatment administered?
The treatment consists of a weekly injection via a pre-filled, easy-to-use pen, combined with a medical follow-up plan. The medication is progressively adjusted to optimise results and minimise potential side effects. The entire process is supervised by a healthcare professional who monitors progress, adapts the strategy as needed, and integrates other support areas such as nutrition, psychology, or physical exercise depending on the case.
What to expect from the personalised weight loss programme?
Initial Consultation:
- Detailed medical evaluation;
- Assessment of blood test results (if required) and evaluation of metabolic parameters;
- Discussion of the therapeutic plan and initiation of treatment, when indicated.
Regular Follow-up:
- Monthly consultations during the first months;
- Subsequently, quarterly consultations (every 3 months);
- Continuous monitoring of weight, metabolic health, and overall wellbeing.
Multidisciplinary Support:
- Complementary intervention in nutrition, psychology, and physical exercise, whenever necessary and upon referral;
- Development of a fully personalised plan adapted to your lifestyle and goals.
Side Effects
Like any medication, GLP-1 agonists can cause side effects. The most common include nausea, a feeling of fullness, constipation, diarrhoea, or acid reflux, especially during the first weeks of treatment, usually transient and manageable with dose adjustments. Although rare, there are potentially serious adverse effects such as acute pancreatitis, gallstones, or, in very specific cases, changes in kidney function. Therefore, the treatment is always started and supervised by a doctor, with careful monitoring of clinical response and the patient’s overall wellbeing.
This consultation represents more than just a treatment — it is a commitment to your long-term health, with continuous support and solutions that respect your body, your pace, and your goals.